Puma Biotechnology (PBYI) Shares Outstanding (Diluted Average) (2020 - 2025)

Puma Biotechnology has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $50.7 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 3.16% year-over-year to $50.7 million; the trailing twelve-month figure through Dec 2025 stood at $50.7 million (up 3.16% YoY), and the FY2025 full-year result was $50.7 million, up 3.16% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $50.7 million, up from $453372.0 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $50.7 million in Q4 2025, with the low at $298896.0 in Q3 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $31.9 million across 5 years, with a median of $41.6 million in 2021.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) soared 16302.06% — and 2025, when it tumbled 99.36%.
• Puma Biotechnology's Shares Outstanding (Diluted Average) stood at $40.6 million in 2021, then grew by 10.56% to $44.9 million in 2022, then grew by 5.83% to $47.6 million in 2023, then advanced by 3.26% to $49.1 million in 2024, then advanced by 3.16% to $50.7 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $50.7 million (Q4 2025), $453372.0 (Q3 2025), and $444487.0 (Q2 2025), per Business Quant data.